Microsomal Epoxide Hydrolase Inhibition
Chem. Res. Toxicol., Vol. 14, No. 4, 2001 415
(
4) Hammock, B. D., Grant, D., and Storms, D. (1997) Epoxide
(22) Argiriadi, M. A., Morisseau, C., Hammock, B. D., and Christian-
son, D. W. (1999) Detoxification of environmental mutagens and
carcinogens: structure, mechanism, and evolution of liver epoxide
hydrolase. Proc. Natl. Acad. Sci. U.S.A. 96, 10637-10642.
(23) Armstrong, R. N. (1999) Kinetic and chemical mechanism of
epoxide hydrolase. Drug Metab. Rev. 31, 71-86.
(24) Roe, E. T., Scanlan, J . T., and Swern, D. (1949) Fatty acid amides.
I. Preparation of amides of oleic and the 9,10-dihydroxystearic
acids. J . Am. Chem. Soc. 71, 2215-2220.
hydrolase. In Comprehensive Toxicology Vol. 3: Biotransformation
(Guengerich, F. P., Ed.) pp 283-305, Pergamon, Oxford, U.K.
(
5) Zheng, J ., Cho, M., Brennan, P., Chichester, C., Buckpitt, A. R.,
J ones, A. D., and Hammock, B. D. (1997) Evidence for quinone
metabolites of naphthalene covalently bound to sulfur nucleo-
philes of proteins of mouse Clara cell after exposure to naphtha-
lene. Chem. Res. Toxicol. 10, 1008-1014.
(
(
(
6) Szeliga, J ., and Dipple, A. (1998) DNA adduct formation by
polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem. Res.
Toxicol. 11, 1-11.
7) Smith, C. A. D., and Harrison, D. J . (1997) Association between
polymorphism in gene for microsomal epoxide hydrolase and
susceptibility to emphysema. Lancet 350, 630-633.
(
(
(
25) Debernard, S., Morisseau, C., Severson, T. F., Feng, L., Wojtasek,
H., Prestwich, G. D., and Hammock, B. D. (1998) Expression and
characterization of the recombinant juvenile hormone epoxide
hydrolase (J HEH) from Manduca sexta. Insect Biochem. Mol. Biol.
2
8, 409-419.
8) Benhamou, S., Reinikainen, M., Bouchary, C., Dayer, P., and
Hirvonen, A. (1998) Association between lung cancer and mi-
crosomal epoxide hydrolase genotypes. Cancer Res. 58, 5291-
26) Grant, D. F., Greene, J . F., Pinot, F., Borhan, B., Moghaddam,
M. F., Hammock, B. D., McCutchen, B., Ohkawa, H., Luo, G.,
and Guenthner, T. M. (1996) Development of an in situ toxicity
assay system using recombinant baculoviruses. Biochem. Phar-
macol. 51, 503-515.
27) Yamada, T., Morisseau, C., Maxwell, J . E., Argiriadi, M. A.,
Christianson, D. W., and Hammock, B. D. (2000) Biochemical
evidence of the involvement of tyrosine in epoxide activation
during the catalytic cycle of epoxide hydrolase. J . Biol. Chem. 275,
5
293.
(
9) Miyata, M., Kudo, G., Lee, Y.-H., Yang, T. J ., Gelboin, H. V.,
Fernandez-Salguero, P., Kimura, S., and Gonzalez, F. J . (1999)
Targeted disruption of the microsomal epoxide hydrolase gene:
microsomal epoxide hydrolase is required for the carcinogenic
activity of 7,12-dimethylbenz[R]anthracene. J . Biol. Chem. 274,
2
3963-23968.
2
3082-23088.
(
10) Vogel-Bindel, U., Bentley, P., and Oesch, F. (1982) Endogenous
role of microsomal epoxide hydrolase: ontogenesis, induction,
inhibition, tissue distribution, immunological behaviour and
purification of microsomal epoxide hydrolase with 16R,17R-
epoxyandrostene-3-one as substrate. Eur. J . Biochem. 126, 425-
(
(
(
28) Segel, I. H. (1993) Enzyme kinetics: behavior and analysis of rapid
equilibrium and steady-state enzyme systems, pp 170-176, J ohn
Wiley & Sons, New York.
29) Kerr, B. M., and Levy, R. H. (1989) Unsubstituted amides: new
class of potent inhibitors of human microsomal epoxide hydrolase.
Drug Metab. Dispos. 18, 540-542.
30) Spiegelstein, O., Kroetz, D. L., Levy, R. H., Yagen, B., Hurst, S.
I., Levi, M., Haj-Yehia, A., and Bialer, M. (2000) Structure-
activity relationship of human microsomal epoxide hydrolase
inhibited by amide and acid analogues of valproic acid. Pharm.
Res. 17, 216-221.
4
31.
(
11) M e´ sange, F., Sebbar, M., Kedjouar, B., Capdevielle, J ., Guillemot,
J .-C., Ferrara, P., Bayard, F., Delarue, F., Faye, J .-C., and Poirot,
M. (1998) Microsomal epoxide hydrolase of rat liver is a subunit
of the anti-oestrogen-binding site. Biochem. J . 334, 107-112.
12) Wang, X., Wang, M., Niu, T., Chen, C., and Xu, X. (1998)
Microsomal epoxide hydrolase polymorphism and risk of sponta-
neous abortion. Epidemiology 9, 540-545.
13) Stirrat, G. M. (1990) Recurrent miscarriage. I. Definition and
epidemiology. Lancet 336, 673-675.
14) Alves, C., Von Dippe, P., Amoui, M., and Levy, D. (1993) Bile acid
transport into hepatocyte smooth endoplasmic reticulum vesicles
is mediated by microsomal epoxide hydrolase, a membrane
protein exhibiting two distinct topological orientations. J . Biol.
Chem. 268, 20148-20155.
(
(
31) Cravatt, B. F., Prosppero-Garcia, O., Siuzdak, G., Gilula, N. B.,
Henriksen, S. J ., Boger, D. L., and Lerner, R. A. (1995) Chemical
characterization of a family of brain lipids that induce sleep.
Science 268, 1506-1509.
(
(
(32) Calignano, A., La Rana, G., Giuffrida, A., and Piomelli, D. (1998)
Control of pain initiation by endogenous cannabinoids. Nature
3
94, 277-281.
(33) Teisier, E., Fennrich, S., Strazielle, N., Daval, J .-L., Ray, D.,
Schlosshauer, B., and Ghersi-Egea, J .-F. (1998) Drug metabolism
in in vitro organotypic and cellular models of mammalian central
nervous system: activities of membrane-bound epoxide hydrolase
and NADPH-cytochrome P-450 (c) reductase. Neurotoxicology 19,
347-356.
(
15) Von Dippe, P., Amoui, M., Stellwagen, R. H., and Levy, D. (1996)
The functional expression of sodium-dependent bile acid transport
in Madin-Darby canine kidney cells transfected with the cDNA
for microsomal epoxide hydrolase. J . Biol. Chem. 271, 18176-
1
8180.
(
16) Oesch, F., Kaubisch, N., J erina, D. M., and Daly, J . W. (1971)
Hepatic epoxide hydrase. Structure-activity relationships for
substrates and inhibitors. Biochemistry 10, 4858-4866.
(34) Boger, D. L., Patterson, J . E., and J in, Q. (1998) Structural
requirements for 5-HT2A and 5-HT1A serotonin receptor poten-
tiation by the biologically active lipid oleamide. Proc. Natl. Acad.
Sci. U.S.A. 95, 4102-4107.
(35) Boger, D. L., Patterson, J . E., Guan, X., Cravatt, B. F., Lerner,
R. A., and Gilula, N. B. (1998) Chemical requirements for
inhibition of gap junction communication by the biologically active
lipid oleamide. Proc. Natl. Acad. Sci. U.S.A. 95, 4810-4815.
(36) Argiriadi, M. A., Morisseau, C., Goodrow, M. H., Dowdy, D. L.,
Hammock, B. D., and Christianson, D. W. (2000) Binding of
alkylurea inhibitors to epoxide hydrolase implicates active site
tyrosines in substrate activation. J . Biol. Chem. 275, 15265-
15270.
(
17) Oesch, F., J erina, D. M., Daly, J . W., and Rice, J . M. (1973)
Induction, activation and inhibition of epoxide hydrase: an
anomalous prevention of chlorobenzene-induced hepatotoxicity by
an inhibitor of epoxide hydrase. Chem.-Biol. Interact. 6, 189-202.
18) Magdalou, J ., and Hammock, B. D. (1988) 1,2-Epoxycyclo-
alkanes: substrates and inhibitors of microsomal and cytosolic
epoxide hydrolases in mouse liver. Biochem. Pharmacol. 37,
(
(
2
717-2722.
19) Kerr, B. M., Rettie, A. E., Eddy, A. C., Loiseau, P., Guyot, M.,
Wilensky, A. J ., and Levy, R. H. (1989) Inhibition of human liver
microsomal epoxide hydrolase by valproate and valpromide: in
vitro/in vivo correlation. Clin. Pharmacol. Ther. 46, 82-93.
20) Draper, A. J ., and Hammock, B. D. (1999) Inhibition of soluble
and microsomal epoxide hydrolase by zinc and other metals.
Toxicol. Sci. 52, 26-32.
(37) Bentley, P., Oesch, F., and Tsugita, A. (1975) Properties and
amino acid composition of pure epoxide hydratase. FEBS Lett.
59, 296-299.
(
(
(
38) Morisseau, C., Derbel, M., Lane, T. R., Stoutamire, D., and
Hammock, B. D. (1999) Differential induction of hepatic drug-
metabolizing enzymes by fenvaleric acid in male rats. Toxicol.
Sci. 52, 148-153.
21) Morisseau, C., Goodrow, M. H., Dowdy, D., Zheng, J ., Greene, J .
F., Sanborn, J . R., and Hammock, B. D. (1999) Potent urea and
carbamate inhibitors of soluble epoxide hydrolases. Proc. Natl.
Acad. Sci. U.S.A. 96, 8849-8854.
TX0001732